2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400
DB03556ExperimentalSmall molecule
2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400: Overview.
![Chemical structure of 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400](/structures/DB03556/thumb.svg)
- Formula / weight
- C18H38O9 · 398.4889 g/mol (avg)
Resolves to
Compound
Structure
InChIKey
CUDPPTPIUWYGFI-UHFFFAOYSA-NSMILESCCOCCOCCOCCOCCOCCOCCOCCOCCOTargets
What you can answer from here — as of August 31, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account